A5058295772- Medication Adherence and Compliance
- Pharmaceutical Practices and Patient Outcomes
- Heart Failure Treatment and Management
- Mobile Health and mHealth Applications
- Pulmonary Hypertension Research and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical studies and practices
- Health Literacy and Information Accessibility
- Clinical Nutrition and Gastroenterology
- Meta-analysis and systematic reviews
- CAR-T cell therapy research
- Intestinal Malrotation and Obstruction Disorders
- Cystic Fibrosis Research Advances
- Blood transfusion and management
- Social Media in Health Education
- Academic integrity and plagiarism
- Neuroblastoma Research and Treatments
- Lymphoma Diagnosis and Treatment
- Artificial Intelligence in Healthcare and Education
- Acute Myeloid Leukemia Research
- Childhood Cancer Survivors' Quality of Life
- Psoriasis: Treatment and Pathogenesis
- Salivary Gland Disorders and Functions
- Patient Safety and Medication Errors
- Hemophilia Treatment and Research
Hospital Universitario Virgen del Rocío
2019-2025
Hospital Universitario de Valme
2024
Instituto de Biomedicina de Sevilla
2021-2024
Universidad de Sevilla
2024
Andalusian Health Service
2024
Background The INCREASE trial introduced a novel therapeutic option for Pulmonary Hypertension caused by Interstitial Lung Disease. Subsequently to this trial, several subgroup analyses were conducted, aiming explore specific effects within subgroups. Objective This study aimed evaluate the performed in and identify potentially reliable effects. Methods A methodological assessment of was performed. Claims effect evaluated using three different tools: Sun, X et al. 2012, Gil-Sierra, M.D 2020,...
In recent years, one of the most successful advances in treating acute myeloid leukaemia (AML) has been combination B-cell lymphoma 2 (BCL-2) inhibitor venetoclax with hypomethylating agents (decitabine or azacytidine). This treatment an accelerated approval by Food and Drug Administration for newly diagnosed AML adults who are 75 years age older have comorbidities not eligible to receive intensive induction chemotherapy. is common form adults, a median at diagnosis 68 years. Consequently,...
<sec> <title>BACKGROUND</title> Pulmonary hypertension (PH), is a chronic and complex condition, requiring consistent management education. The widespread use of smartphones has opened possibilities for mobile health apps to support both patients healthcare professionals in monitoring managing PH more effectively. </sec> <title>OBJECTIVE</title> review aimed identify assess the quality free smartphone targeted at professionals. <title>METHODS</title> A systematic search was conducted on...
Objetivo: analizar las características demográficas, clínicas y funcionales de personas residentes en un centro sociosanitario público. Caracterizar a la población función del riesgo anticolinérgico según escala DBI. Metodología: estudio observacional descriptivo una cohorte público Andalucía. Se llevó cabo desde septiembre hasta diciembre 2020.Se recogieron variables sociodemográficas, funcionales, farmacoterapia carga anticolinérgica asociada realizó análisis general otro diferencial...
<h3>Background and Importance</h3> Retractions in scientific literature can profoundly impact healthcare professionals, potentially misleading hospital pharmacists affecting patient safety. <h3>Aim Objectives</h3> This study aimed to provide a focused examination of article retractions pharmacological research. <h3>Material Methods</h3> A cross-sectional observational was carried out using data from the recently released (10/09/2023) 'Retraction Watch Database'* which compiles retracted...
<h3>Background and Importance</h3> The ESC/ERS Guidelines for treating pulmonary hypertension (PH) recommend vasoreactivity testing (VT) during right heart catheterisation patients with idiopathic/hereditable/drug-associated PH (IPH/HPH/DAPH) subsequent treatment calcium channel blockers in those a positive result. <h3>Aim Objectives</h3> To evaluate the consistency conducting VT IPH/HPH/DAPH to ascertain whether test outcomes lead initiation of blocker therapy. <h3>Material Methods</h3> We...
<h3>Background and Importance</h3> Hospital pharmacists patients face challenges in identifying high-quality, functional smartphone applications (apps) for aiding pulmonary hypertension (PH) management. A thorough, user-centred evaluation is required due to these app's role medication management patient education. <h3>Aim Objectives</h3> To evaluate the quality utility of PH-focused apps from perspectives hospital patients. <h3>Material Methods</h3> An observational study was conducted on...
La insuficiencia cardiaca es un síndrome prevalente y con alta mortalidad, que representa una carga económica significativa en términos de atención sanitaria. Hasta el momento, no se disponen estudios metodología robusta aporten información sobre los patrones tratamiento, la adherencia persistencia pacientes reales cardiaca. describir las características clínicas, manejo terapéutico, adherencia, resultados clínicos, así como asociación entre estas variables, cohorte comunidad autónoma...
Heart failure is a prevalent syndrome with high mortality rates, representing significant economic burden in terms of healthcare. The lack systematic information about the treatment and adherence patients heart limits understanding these aspects potentially improvement clinical outcomes. To describe characteristics, therapeutic management, adherence, persistence, results, as well association between variables, cohort Andalusia. This study will be an observational, population-based,...
Background: home parenteral nutrition (HPN) is a technique that allows increasing the survival of patients with intestinal failure. Aim: to study evolution over last 8 years in our center. Methods: retrospective adult receiving HPN between 2011 and 2019. Study variables are expressed as frequency mean ± SD (range). Parametric, non-parametric tests, analysis (p < 0.05) were applied. Results: use showed substantial increase (up 154 %). A total 76 received HPN, 76.32 % had an oncological...